The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Smart insulin pens are expected to drive the insulin pen market from $13.8 billion in 2020 to more than $16 billion by 2030, according to GlobalData. Image. Phil Taylor. 8 November, 2022.

DELRAY BEACH, Fla., June 25, 2025 /PRNewswire/ -- The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is projected to advance at ...

Danish pharma giant Novo Nordisk’s announcement comes months after the launch of another top selling obesity drug Mounjaro in India by US based pharma giant Eli Lilly & Company.

According to the company, the Bigfoot Unity reimagines treatment for people with diabetes with a holistic solution featuring first-of-its-kind smart insulin pen caps delivering on-demand dose ...

Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...

For the vial and syringe group, the total number of subcutaneous injections was converted to the total number of syringes used. In the insulin pen group, if the number of units of insulin consumed per ...

Patient satisfaction. More patients in the insulin pen group (77.1%) dialed at least one dose of insulin using the pen device, compared with 5% of patients who drew at least one dose using the ...

Billed as an alternative to insulin injections, the Australian creators of the insulin pill were handed a million-dollar ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...